1. Elliott

    0 Comments Leave a Comment

    1-15 of 105 1 2 3 4 5 6 7 »
    1. Mentioned In 105 Articles

    2. Omega Therapeutics Strengthens Board of Directors with Appointment of R&D Veteran Elliott M. Levy, M.D.

      Omega Therapeutics Strengthens Board of Directors with Appointment of R&D Veteran Elliott M. Levy, M.D.
      CAMBRIDGE, Mass.,May 20, 2021/PRNewswire/ -- Omega Therapeutics, Inc. ("Omega"), a development-stage biotechnology company leveraging its OMEGA Epigenomic Programming platform to harness the power of epigenetics and pioneer novel DNA-sequence-based targets and develop a new class of mRNA-encoded programmable epigenetic medicines, today announced the appointment ofElliott M. Levy, M.D., to its Board of Directors...
      Read Full Article
    3. 1-15 of 105 1 2 3 4 5 6 7 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes about Elliott

    1. We are determined that they (Elliott) will not mislead our shareholders.
      In Alliance Trust, Elliott's clash over directors escalates
    2. Elliott would pursue a short-term agenda aimed at facilitating an exit from its shareholding in the company. Given the size of its position, this would involve disruptive actions which are not in the long-term interests of our shareholders.
      In Alliance Trust, Elliott's clash over directors escalates
    3. Elliott believes operational and governance improvements would allow Pernod to unlock much of the value that the company is capable of delivering, improving the strength and sustainability of the company for all stakeholders.
      In Activist Investor Elliott Faces Hostility Over Pernod Ricard Stake